Goldman Sachs’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-458,096
| Closed | -$15.5M | – | 5741 |
|
2021
Q2 | $15.5M | Sell |
458,096
-228,512
| -33% | -$7.72M | ﹤0.01% | 1925 |
|
2021
Q1 | $16.1M | Sell |
686,608
-25,057
| -4% | -$586K | ﹤0.01% | 1836 |
|
2020
Q4 | $20.5M | Buy |
711,665
+341,483
| +92% | +$9.83M | 0.01% | 1548 |
|
2020
Q3 | $7.5M | Buy |
370,182
+42,890
| +13% | +$869K | ﹤0.01% | 2139 |
|
2020
Q2 | $9.84M | Buy |
327,292
+235,860
| +258% | +$7.09M | ﹤0.01% | 1956 |
|
2020
Q1 | $2.87M | Buy |
91,432
+78,094
| +586% | +$2.45M | ﹤0.01% | 2566 |
|
2019
Q4 | $628K | Sell |
13,338
-19,309
| -59% | -$909K | ﹤0.01% | 3539 |
|
2019
Q3 | $211K | Buy |
+32,647
| New | +$211K | ﹤0.01% | 3902 |
|
2019
Q2 | – | Sell |
-10,779
| Closed | -$146K | – | 4344 |
|
2019
Q1 | $146K | Buy |
+10,779
| New | +$146K | ﹤0.01% | 3956 |
|
2018
Q4 | – | Sell |
-15,301
| Closed | -$103K | – | 4328 |
|
2018
Q3 | $103K | Buy |
+15,301
| New | +$103K | ﹤0.01% | 3950 |
|